ADRENALINE BRADEX 1 mg/mL, solution injectable Franza - Franċiż - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

adrenaline bradex 1 mg/ml, solution injectable

bradex commercial and industrial pharmaceutical products s.a. - adrénaline - solution - 1 mg - composition pour une ampoule de 1 ml > adrénaline : 1 mg . sous forme de : tartrate d'adrénaline - agents adrénergiques et dopaminergiques, adrénaline

Noradrenaline Added Pharma 0,5 mg/ml sol. perf. i.v. flac. Belġju - Franċiż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline added pharma 0,5 mg/ml sol. perf. i.v. flac.

added pharma b.v. - bitartrate de norépinéphrine 1 mg/ml - eq. norépinéphrine 0,5 mg/ml - solution pour perfusion - 0,5 mg/ml - bitartrate de norépinéphrine 1 mg/ml - norepinephrine

Noradrenaline Kabi 1 mg/ml sol. perf. (à diluer) i.v. amp. Belġju - Franċiż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline kabi 1 mg/ml sol. perf. (à diluer) i.v. amp.

fresenius kabi sa-nv - bitartrate de norépinéphrine 2 mg/ml - eq. norépinéphrine 1 mg/ml - solution à diluer pour perfusion - 1 mg/ml - bitartrate de norépinéphrine 2 mg/ml - norepinephrine

Noradrenaline Kabi 1 mg/ml sol. perf. (à diluer) i.v. amp. Belġju - Franċiż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline kabi 1 mg/ml sol. perf. (à diluer) i.v. amp.

fresenius kabi sa-nv - bitartrate de norépinéphrine 2 mg/ml - eq. norépinéphrine 1 mg/ml - solution à diluer pour perfusion - 1 mg/ml - bitartrate de norépinéphrine 2 mg/ml - norepinephrine

Noradrenaline Kabi 1 mg/ml sol. perf. (à diluer) i.v. amp. Belġju - Franċiż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline kabi 1 mg/ml sol. perf. (à diluer) i.v. amp.

fresenius kabi sa-nv - bitartrate de norépinéphrine 2 mg/ml - eq. norépinéphrine 1 mg/ml - solution à diluer pour perfusion - 1 mg/ml - bitartrate de norépinéphrine 2 mg/ml - norepinephrine

Noradrenaline Kabi 1 mg/ml sol. perf. (à diluer) i.v. amp. Belġju - Franċiż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline kabi 1 mg/ml sol. perf. (à diluer) i.v. amp.

fresenius kabi sa-nv - bitartrate de norépinéphrine 2 mg/ml - eq. norépinéphrine 1 mg/ml - solution à diluer pour perfusion - 1 mg/ml - bitartrate de norépinéphrine 2 mg/ml - norepinephrine

Noradrenaline Kabi 1 mg/ml sol. perf. (à diluer) i.v. amp. Belġju - Franċiż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline kabi 1 mg/ml sol. perf. (à diluer) i.v. amp.

fresenius kabi sa-nv - bitartrate de norépinéphrine 2 mg/ml - eq. norépinéphrine 1 mg/ml - solution à diluer pour perfusion - 1 mg/ml - bitartrate de norépinéphrine 2 mg/ml - norepinephrine

2% XYLOCAINE DENTAL WITH ADRENALINE 1:80,000 2.2mL injection cartridge Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

2% xylocaine dental with adrenaline 1:80,000 2.2ml injection cartridge

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

BUPIVACAINE 0.5% WITH ADRENALINE 1:200,000 PHEBRA bupivacaine HCl 100 mg/20 mL with adrenaline 100 microgram/20 mL solution for injection vial Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

bupivacaine 0.5% with adrenaline 1:200,000 phebra bupivacaine hcl 100 mg/20 ml with adrenaline 100 microgram/20 ml solution for injection vial

phebra pty ltd - bupivacaine hydrochloride monohydrate, quantity: 105.54 mg (equivalent: bupivacaine hydrochloride, qty 100 mg); adrenaline (epinephrine) acid tartrate, quantity: 182 microgram (equivalent: adrenaline (epinephrine), qty 100 microgram) - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium chloride; water for injections - bupivacaine 0.5% with adrenaline 1:200,000 phebra is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows:,surgical anaesthesia ? epidural block for surgery ? field block (minor and major nerve blocks and infiltration) analgesia ? intermittent bolus epidural administration for analgesia in postoperative pain or labour pain ? field block (minor nerve block and infiltration)

4% Articadent DENTAL with adrenaline (epinephrine) 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 2.2 mL injection cartridge Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

4% articadent dental with adrenaline (epinephrine) 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 2.2 ml injection cartridge

dentsply sirona pty ltd - articaine hydrochloride, quantity: 40 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; sodium hydroxide; hydrochloric acid; water for injections - 4 percent articadent dental with adrenaline 1:100,000 is indicated for local or regional anaesthesia for both simple and complex dental procedures in adults, adolescents and children 4 years of age and older. 4 percent articadent dental with adrenaline 1:100,000 is indicated only for dental procedures.